Digital tool for managing liver disease in young patients
Integrated System for Patients Who Belong the Transition to Adult Services and Are Undergoing a Liver Transplant
This study is testing a new digital tool to help young people with liver disease manage their care better as they transition from pediatric to adult healthcare.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 14 Years to 20 Years |
| Sex | All |
| Sponsor | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS Academic / other |
| Locations | 1 site (Bergamo, MILANO) |
| Trial ID | NCT06342557 on ClinicalTrials.gov |
What this trial studies
This observational study is part of the MACROLIVER Project, which aims to develop a digital tool to assist patients and caregivers in managing liver disease, particularly during the transition from pediatric to adult care. The study focuses on patients aged 14 to 20 who have undergone or are awaiting liver transplants, gathering data to identify factors affecting their psychological well-being. By optimizing therapy and treatment processes remotely, the tool seeks to enhance access to care while minimizing the need for patient travel. The study will also collect retrospective data to provide a comprehensive clinical-psychological picture of these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 14 to 20 who have received or are awaiting a liver transplant and are transitioning to adult services.
Not a fit: Patients outside the age range of 14 to 20 or those not undergoing a liver transplant will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and psychological support for young liver transplant patients during their transition to adult care.
How similar studies have performed: While this approach is innovative in its specific focus on the transition from pediatric to adult care, similar digital health interventions have shown promise in other areas of chronic disease management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients between the ages of 14 and 20 who have been transplanted at the ASST-PG23 transplant center or are awaiting a liver transplant and belong to the transition to adult services * signed informed consent * proven use of the APPs (to be assessed based on the last 2 weeks) Exclusion Criteria: \-
Where this trial is running
Bergamo, MILANO
- ASST-Papa Giovanni XXIII — Bergamo, Milano, Italy (Recruiting)
Study contacts
- Principal investigator: Stefano Fagiuoli, MD — Asst-Pg23
- Study coordinator: Pietro Giani, BS
- Email: gastroenterologia.liver@asstpg23.it
- Phone: 035.2675134
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.